-
-
-
-
-
-
-
Charles River Laboratories (CRL) Tops Q1 EPS by 12c, provides guidance
-
-
-
-
-
-
-
Charles River partners with Gazi University for rare disease therapy
-
-
-
-
-
-
-
Baird Upgrades Charles River Labs (CRL) to Outperform
-
-
-
-
-
-
-
Charles River Labs (CRL) PT Raised to $175 at BofA Securities
-
-
-
-
-
-
-
Charles River Labs (CRL) PT Raised to $180 at Deutsche Bank
-
-
-
-
-
-
-
Goldman Sachs Downgrades Charles River Labs (CRL) to Neutral
-
-
-
-
-
-
-
William Blair Downgrades Charles River Labs (CRL) to Market Perform
-
408,269 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

